Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$105.25 USD
-0.21 (-0.20%)
Updated May 31, 2024 04:00 PM ET
After-Market: $105.27 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Jazz Pharmaceuticals PLC [JAZZ]
Reports for Purchase
Showing records 101 - 120 ( 248 total )
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
3Q19: Xyrem, Tax Rate, Beat, Repeat. Very Conservative Guidance Unsurprisingly Raised.
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
2Q19: Another Xyrem-Driven Beat; Confusingly Conservative EPS Guidance Has Investors Scratching Heads; Lower PT to $147
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
Company: Jazz Pharmaceuticals PLC
Industry: Medical - Drugs
1Q19 Results: Conservative Guidance Yielding Blowout Results, but Quarters Have Been Opaque; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O